Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer > Conference

Skip to content

Publications

Sub Visual

Conference

2012 Intratumoral metabolic heterogeneity can predict disease progression a…

Post author info

profile_image
  • Author 분자영상테라노스틱스연구소
  • Date 17-12-19 11:25
  • Views 3
  • Comments 0

Post content

Basic info

Basic info
Institution name 제 51차 대한핵의학회 추계학술대회
Title Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer
Speaker Sae-Ryung Kang, Ho-Chun Song, Byung Hyun Byun, Jong-Ryool Oh, Jahae Kim, Su Woong Yoo, Sang-Geon Cho, Hee Jeong Park, Jung-Joon Min, Hee-Seung Bom 10명
Intratumoral metabolic heterogeneity can predict disease progression after cancurrent chemoradiotherapy in patients with inoperable stage III non-small cell lung cancer